Depression of Growth in Hyperactive Children on Stimulant Drugs

New England Journal of Medicine

Volumn 287, Issue 5, 1972, Pages 217-220

  Safer, Daniel ^a   Allen, Richard ^a   Barr, Evelyn ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GROWTH; HUMAN; HYPERKINESIA; MALE;

BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL TRIALS; DEXTROAMPHETAMINE; GROWTH; HUMANS; HYPERKINESIS; MALE; METHYLPHENIDATE;

EID: 0015493134     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197208032870503     Document Type: Article

References (18)

1. Knights RM, Hinton GG: The effects of methylphenidate (ritalin) on the motor skills and behavior of children with learning problems. J Nerv Ment Dis 148: 643-653, 1969
2. Eisenberg L, Lachman R. Molling PA, et al: A psychopharmacologic experiment in a training school for delinquent boys: methods, problems, findings. Am J Orthopsychiatry 33: 431-447, 1963
3. Innes IK, Nickerson MN: Drugs acting on postganglionic adrenergic nerve endings and structures innervated by them (sympathomimetic drugs), The Pharmacological Basis of Therapeutics. Fourth edition. Edited by L Goodman, A Gilman. New York, The MacMillan Company, 1970, pp 478-523
4. Lorber J: Obesity in childhood: a controlled trial of anorectic drugs. Arch Dis Child 41: 309-312, 1966
5. DiMascio A, Soltys J, Shader R: Psychotropic drug side effects in children, Psychotropic Drug Side Effects: Clinical and theoretical perspectives. Edited by R Shader, A DiMascio. Baltimore, Williams and Wilkins Company, 1970, pp 235-260
6. Vaughan V III: Growth and development, Textbook of Pediatrics. Ninth edition. Edited by WE Nelson. Philadelphia, WB Saunders Company, 1969, pp 15-57
7. Siegel S: Nonparametric Statistics for the Behavioral Sciences. New York, McGraw-Hill Book Company, 1956
8. Jaffe JH: Drug addiction and drug abuse, The Pharmacological Basis of Therapeutics. Fourth edition. Edited by L Goodman, A Gilman. New York, The MacMillan Company, 1970, pp 276-313
9. Tormey J, Lasagna L: Relation of thyroid function to acute and chronic effects of amphetamine in the rat. J Pharmacol Exp Ther 128: 201-209, 1960
10. Conners CK: Recent drug studies with hyperkinetic children. J Learn Disabil 4: 476-483, 1971
11. Silverstone JT, Stunkard AJ: The anorectic effect of dexamphetamine sulfate. Br J Pharmacol Chemother 33: 513-522, 1968
12. Santi R, Fassina G: Dexamphetamine and lipid mobilization in obesity. J Pharm Pharmacol 16: 130-131, 1964
13. Pinter E, Pattee C: Fat mobilizing action of amphetamine, Amphetamines and Related Compounds. Edited by E Costa, S Garattini. New York, Raven Press, 1970, pp 653-671
14. Modell W: Status and prospect of drugs for overeating. JAMA 173: 1131-1136, 1960
15. Oswald I: Sleep and dependence on amphetamine and other drugs, Sleep: Physiology and pathology. Edited by A Kales. Philadelphia, JB Lippincott Company, 1969, pp 317-330
16. Honda Y, Takahashi K, Takahashi S et al: Growth hormone secretion during nocturnal sleep in normal subjects. J Clin Endocrinol Metab 29: 20-29, 1969
17. Laufer MW: Long-term management and some follow-up findings on the use of drugs with minimal cerebral syndromes. J Learn Disabil 4: 518-522, 1971
18. Farner D: Untersuchungen über die Wirkung von Pharmaka auf Tiere verschiedenen Alters. III. Mitteilung: Die Beeinflussung des Appetites durch Amphetamin (Benzedrin) und Preludin bei Ratten verschiedenen Alters. Gerontologia 5: 35-44, 1961